AngioDynamics injunction
This article was originally published in The Gray Sheet
Executive Summary
AngioDynamics will begin shipping NeverTouch VenaCure varicose vein laser treatment procedure kits June 2 to replace orders for its VenaCure laser following a ruling in Boston Federal District Court upholding a March jury verdict that VenaCure infringes on a Diomed patent for the EndoVenous laser system (1"The Gray Sheet" April 16, 2007, p. 16). The court ruled May 22 that Diomed is entitled to a permanent injunction, and instructed both parties to agree upon specific terms by May 29. In addition, the verdict orders AngioDynamics to pay an additional $1.35 million in damages to cover pretrial interest and post verdict sales of VenaCure, bringing total damages against the company to $9.71 million. AngioDynamics stopped shipment of VenaCure April 27...
You may also be interested in...
Angiodynamics Looks To Overcome Legal Woes, Regain Momentum
Angiodynamics' plan to sidestep patent infringement concerns relating to its VenaCure laser system for varicose veins could help boost sales growth and lift the cloud over the firm's stock performance after a poor showing in the first quarter
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.